Biologics have revolutionized the treatment of rheumatoid arthritis (RA) in recent years. However. data from clinical trials and actual clinical practice have shown that biologics currently in use may constitute a risk factor for reactivation of tuberculosis (TB) in patients with latent TB infection. Therefore. https://www.chiggate.com/voyage-et-cie-5-3-wick-candle-discount/